Hydroxychloroquine, an antimalarial drug, is used commonly for mild manifestations of SLE and other connective tissue diseases, particularly rashes and
Antimalarial drugs, such as hydroxychloroquine (Plaquenil) and chloroquine, are standard treatments for SLE. They can help control lupus symptoms like fatigue
by ÓR Peña-Vizcarra 2024 Cited by 3Evidence for antimalarial drug efficacy in SLE proceeds from a HN. Ophthalmologic safety profile of antimalarial drugs . Lupus. 2024.
Hydroxychloroquine, an antimalarial drug approved by the FDA in 2024, plays a significant role in treating systemic lupus erythematosus (SLE)
Overall, antimalarial drugs have numerous beneficial effects in patients with SLE and lupus nephritis, and have a good safety profile.
Hydroxychloroquine, an antimalarial drug, is used commonly for mild manifestations of SLE and other connective tissue diseases, particularly rashes and
Hydroxychloroquine (HCQ; Plaquenil) is an antimalarial drug that has been used in autoimmune infectious diseases, specifically in SLE. HCQ
Hydroxychloroquine (HCQ; Plaquenil) is an antimalarial drug that has been used in autoimmune infectious diseases, specifically in SLE. HCQ is an
by N Rothfield 2024 Cited by 45No recent study has been published on the efficacy of antimalarial drugs in the treatment of systemic lupus erythematosus (SLE). However, antimalarial drug
Comments
LWlurker